FMO1:FAD N-oxidises TAM

Stable Identifier
R-HSA-217255
Type
Reaction
Species
Homo sapiens
Compartment
Synonyms
FMO1 N-oxidizes the anti-cancer drug tamoxifen
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Tamoxifen (TAM) is an antiestrogen and currently used extensively for breast cancer therapy. FMOs, especially FMO1 can N-oxidze TAM to tamoxifen N-oxide (TNO). TNO can be reduced back to TAM by the P450 system. TNO appears to be just as potent as TAM but with fewer side-effects so this metabolic cycling could play a part in the use of TNO in the treatment of breast cancer.

Participants
Participant Of
Catalyst Activity
Catalyst Activity
Title
N,N-dimethylaniline monooxygenase activity of FMO1:FAD [endoplasmic reticulum membrane]
Physical Entity
Activity
Orthologous Events
Authored
Reviewed
Created
Cite Us!